Our findings not only reveal a novel HA/CD44/TGFβ signaling axis that is implicated in Alport renal fibrosis but also suggest a promising strategy to inhibit renal fibrosis by specifically blocking HA/CD44 activation via the inhibition of HA production, CD44 activation or the HA‒CD44 interaction. This evidence concerns the gene CD44 and renal fibrosis.